Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $109.75.
Several research analysts recently issued reports on ALAB shares. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Needham & Company LLC reissued a “buy” rating and issued a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft boosted their price target on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Citigroup assumed coverage on Astera Labs in a research note on Monday, November 18th. They set a “buy” rating and a $120.00 price objective for the company. Finally, Morgan Stanley boosted their target price on shares of Astera Labs from $94.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, December 20th.
View Our Latest Research Report on Astera Labs
Insiders Place Their Bets
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. ORG Wealth Partners LLC bought a new stake in shares of Astera Labs during the fourth quarter worth approximately $42,000. Hollencrest Capital Management acquired a new stake in Astera Labs during the 3rd quarter worth $26,000. GAMMA Investing LLC grew its holdings in Astera Labs by 78.3% during the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock worth $68,000 after acquiring an additional 224 shares during the period. US Bancorp DE bought a new stake in shares of Astera Labs during the 3rd quarter valued at $46,000. Finally, First Horizon Advisors Inc. acquired a new position in shares of Astera Labs in the 3rd quarter valued at $49,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Astera Labs Stock Performance
Shares of NASDAQ ALAB opened at $133.30 on Wednesday. Astera Labs has a one year low of $36.22 and a one year high of $147.39. The business has a fifty day simple moving average of $118.88 and a 200 day simple moving average of $76.01.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The business’s revenue for the quarter was up 47.1% compared to the same quarter last year. Analysts predict that Astera Labs will post -0.45 earnings per share for the current year.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More
- Five stocks we like better than Astera Labs
- Election Stocks: How Elections Affect the Stock Market
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Ride Out The Recession With These Dividend Kings
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Market Cap Calculator: How to Calculate Market Cap
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.